2012
DOI: 10.1002/cyto.b.21052
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage

Abstract: Background: The Kleihauer-Betke test (KBT) is the most widely used assay for fetomaternal hemorrhage (FMH) detection in rhesus D negative women. In the current study, we sought to evaluate the performance of a flow cytometry (FCM) kit (FMH QuikQuant) using an anti-HbF antibody.Methods: Eighty-three pregnant women, 58 umbilical cord blood (UCB) dilutions in adult blood, and 6 control samples were tested in parallel with FCM and KBT.Results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
5

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 33 publications
1
12
0
5
Order By: Relevance
“…These 'low' values artificially inflate the imprecision between the WinList replicate analyses. If these values are excluded, then the CVs would be approximately 4% and 7% for the manual intra-analyst and interanalyst analyses, respectively, which is in keeping with previous reports [6,[9][10][11]. If such variation is observed in expert analyses, we anticipate that it would even higher for nonexperts, where CV is typically reported in the range of 10-30% from regional proficiency testing programs for FMH testing by flow cytometry, such as those run by the College of American Pathologist or UK NEQAS programs.…”
Section: Discussionmentioning
confidence: 61%
“…These 'low' values artificially inflate the imprecision between the WinList replicate analyses. If these values are excluded, then the CVs would be approximately 4% and 7% for the manual intra-analyst and interanalyst analyses, respectively, which is in keeping with previous reports [6,[9][10][11]. If such variation is observed in expert analyses, we anticipate that it would even higher for nonexperts, where CV is typically reported in the range of 10-30% from regional proficiency testing programs for FMH testing by flow cytometry, such as those run by the College of American Pathologist or UK NEQAS programs.…”
Section: Discussionmentioning
confidence: 61%
“…Although anti‐HbF FC calculated higher FMH volumes compared to the results generated by the currently used anti‐D FC method, this overestimation is insignificant at lower FMH volumes as one 1500 IU dose of anti‐D prophylaxis is issued to treat an FMH of <12 mL in our institution. Anti‐HbF FC allows FMH to be detected in women regardless of their RhD status and would prove helpful in haemoglobin‐based diseases, such as hereditary persistence of fetal haemoglobin (HPFH) or myelodysplastic syndromes (Pastoret et al, ). However, using the anti‐D FC method, it is easier to detect FMH in RhD‐negative women with an RhD‐positive infant as it shows greater peak separation.…”
Section: Discussionmentioning
confidence: 99%
“…In our study we use FCM method to determine FMH volume that occurred during labor and prefer it than other techniques as it has better precision, can prevent false-positive results in patients with increased F-cell counts due to other conditions [9] [10] [11]. Because maternal F cells have been reported to increase during the second trimester of pregnancy and misidentification of these F cells as fetal RBCs may occur especially in pregnant women with hereditary persistence of fetal hemoglobin, sickle cell disease, thalassemia, or a hematologic malignancy [27] [28] [29]. Formally (KBT) was based on the microscopic counting of fetal RBCs within the maternal blood on blood film, under acid conditions, it is inaccurate, leading to inappropriate dose of anti-Rh D immunoglobulin [13]- [30].…”
Section: Discussionmentioning
confidence: 99%